Recombinant Human MPZ Protein，His

MPZ (myelin protein zero) is a key structural protein in the peripheral nervous system, primarily involved in the formation and maintenance of myelin sheaths around neuronal axons. Its significance is underscored by its role in myelination, which is crucial for the proper functioning of the nervous system. Abnormalities in MPZ expression or function are linked to various neuropathies, particularly Charcot-Marie-Tooth disease (CMT), a hereditary condition characterized by progressive weakness and atrophy of the limbs. Research into MPZ recombinant proteins seeks to explore their structural and functional properties, providing insights into myelination processes and potential therapeutic approaches for demyelinating diseases. By engineering MPZ variants, scientists aim to understand the protein's interactions with other myelin components and identify the mechanisms underlying myelin sheath assembly. Additionally, the development of MPZ-based therapies holds promise for regenerative medicine and neuroprotection, as elucidating MPZ functionality could pave the way for innovative treatments targeting myelin repair in peripheral neuropathies. As such, MPZ recombinant protein research is not only vital for basic scientific understanding but also for developing clinical applications that may enhance the quality of life for individuals affected by myelin-related disorders.